Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes.
about
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en-gb
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@nl
type
label
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en-gb
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@nl
prefLabel
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en-gb
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@nl
P2093
P50
P1154
2-s2.0-84890851726
P1433
P1476
Blocking oncogenic RAS enhance ...... lity to cytotoxic lymphocytes.
@en
P2093
G Eric Blair
Gina B Scott
Josephine L Meade
Paul A Bowles
Robin Prestwich
Ruth S M Morgan
Tomoyuki Tanaka
P304
P356
10.1016/J.MOLIMM.2013.11.020
P577
2013-12-22T00:00:00Z